NVIV

InVivo Therapeutics Holdings Corp

Delisted

NVIV was delisted on the 12th of February, 2024.

37 hedge funds and large institutions have $15.9M invested in InVivo Therapeutics Holdings Corp in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
$117K
Net Calls
Net Calls Change

Top Buyers

1 +$1.31M
2 +$1.09M
3 +$434K
4
ECM
Element Capital Management
New York
+$368K
5
Goldman Sachs
Goldman Sachs
New York
+$251K

Top Sellers

1 -$3.71M
2 -$987K
3 -$805K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$562K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$420K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$81K
27
$70K
28
$64K
29
$63K
30
$58K
31
$57K
32
$52K
33
$52K
34
$47K
35
$34K
36
$32K
37
$27K
38
$25K
39
$24K
40
$11K
41
$3K
42
$3K
43
$2K
44
$1K
45
$1K
46
$1K
47
$1K
48
$30
49
50